OMCL

Omnicell Inc
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$1.63B
P/E Ratio
42.80
EPS
$0.84
Beta
0.99
52W High
$55.00
52W Low
$29.09
50-Day MA
$34.63
200-Day MA
$39.69
Dividend Yield
—
Profit Margin
3.14%
Forward P/E
29.50
PEG Ratio
15.40

About Omnicell Inc

Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.25B
Gross Profit (TTM)$548.73M
EBITDA$82.18M
Operating Margin5.91%
Return on Equity3.06%
Return on Assets1.52%
Revenue/Share (TTM)$27.49
Book Value$28.32
Price-to-Book1.17
Price-to-Sales (TTM)1.31
EV/Revenue1.122
EV/EBITDA9.82
Quarterly Earnings Growth (YoY)333.30%
Quarterly Revenue Growth (YoY)7.50%
Shares Outstanding$45.48M
Float$44.38M
% Insiders2.15%
% Institutions109.10%

Historical Volatility

HV 10-Day
35.46%
HV 20-Day
27.90%
HV 30-Day
29.74%
HV 60-Day
42.68%
HV Rank
2.4%

Volatility is currently expanding

Analyst Ratings

Consensus ($57.86 target)
1
Strong Buy
6
Buy
1
Hold

Latest News

Here's Why Omnicell (OMCL) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research8/4/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OMCL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026